Skip to main content
Clinical Trials/NCT04891107
NCT04891107
Completed
N/A

Feasibility and Preliminary Effects of Using a Music-based, Rhythm-modulating Wearable Sensor System in the Community in Persons With Parkinson Disease

MedRhythms, Inc.2 sites in 1 country26 target enrollmentJuly 2, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
MedRhythms, Inc.
Enrollment
26
Locations
2
Primary Endpoint
Usability (Feasibility) Based on Participant Ratings on Acceptability and Usability Questionnaire.
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this clinical study is to evaluate the effects of music, tailored to the participant's cadence, on adherence, quality of life, gait speed, functional mobility, and walking activity in individuals with Parkinson disease when used in the home and community environment.

Detailed Description

Persons with Parkinson disease will be enrolled to determine the effects of a community walking program with a music-based device on adherence, quality of life, walking speed and walking activity. The walking program will be carried out independently by participants in their home/community environment. Noninvasive functional assessments commonly administered in clinical practice will be used to measure the variables of interest.

Registry
clinicaltrials.gov
Start Date
July 2, 2021
End Date
June 8, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of idiopathic, typical Parkinson disease.
  • Modified Hoehn and Yahr stages 1-3 per physical exam.
  • Able to walk independently without physical assistance or an assistive device.

Exclusion Criteria

  • Diagnosis of atypical Parkinsonism.
  • Moderately or significantly disturbing freezing episodes during daily walking.
  • Cognitive impairment as determined by the Montreal Cognitive Assessment (MoCA).
  • Significant hearing impairment.
  • Currently participating in physical therapy.
  • Cardiac problems that interfere with the ability to safely exercise.
  • Orthopedic problems in the lower extremities or spine that may limit walking distance.

Outcomes

Primary Outcomes

Usability (Feasibility) Based on Participant Ratings on Acceptability and Usability Questionnaire.

Time Frame: 28 days

Usability as assessed by participant ratings on Acceptability and Usability Questionnaire. The Questionnaire is comprised of adapted items from the System Usability Scale, Post Study System Usability Questionnaire, Technology Assessment Model Measurement Scales, and Usefulness, Satisfaction, and Ease questionnaire as described in Ben-Zeev D, et al., 2014. Participants were asked to rate their agreement with a series of statements about the intervention (26-items) using three Likert Scale responses (disagree, neutral, or agree) for each item. The number of responses in each category of disagree, neutral, or agree were summed and averaged across the total number of participants who responded to report an overall percentage within each category of disagree, neutral, or agree on the acceptability and usability of the device. A higher overall percentage of 'agree' responses indicate a higher degree of usability as rated by participants.

Observed Adherence (Feasibility) to Walking Program Schedule Based on Percentage of Scheduled Sessions Completed

Time Frame: 28 days

Percentage of scheduled sessions completed (5 times per week for 4 weeks)

Safety (Feasibility) Based on the Number of Adverse Events During Training

Time Frame: 28 days

Safety as assessed by number of adverse events during training with the music-based device

Change in Mobility Impact Based on the Mobility Dimension of the Parkinson's Disease Questionnaire-39 (PDQ-39) Between Baseline to Last Visit

Time Frame: 28 days

Mobility impact as assessed by Parkinson's Disease Questionnaire-39 (PDQ-39) mobility dimension (questions #1-10 from the total PDQ-39 questionnaire). Each question is scored on a 0-4 ordinal scoring system then summed to generate the sub-scale score of the mobility dimension. Lower scores represent better quality of life. Mobility Dimension Subscale Range: 0-100

Secondary Outcomes

  • Overall Quality of Life Impact Based on the Total Parkinson's Disease Questionnaire -39 (PDQ-39)(28 days)
  • Change in Disease Severity Based on the Movement Disorders Society Unified Parkinson's Disease Rating Scale Part III (MDS-UPDRS III)(28 days)
  • Change in Walking Endurance (m)(28 days)
  • Change in Fast Walking Gait Speed (m/s)(28 days)
  • Change in Intensity (Moderate Intensity Minutes; >100 Steps/Min)(8 days)
  • Change in Mobility(28 days)
  • Change in Amount of Walking (Steps/Day)(8 days)

Study Sites (2)

Loading locations...

Similar Trials